查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379057

抗真菌藥物市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球抗真菌藥物市場規模達146億美元。展望未來， IMARC Group預計到2028年市場規模將達到180億美元，2022-2028年複合年成長率（CAGR）為3.6%。

抗真菌藥物，或稱抗真菌藥物，指用於治療皮膚、頭髮和指甲的真菌感染的藥物。一些常用的抗真菌藥物包括多烯類、唑類和烯丙胺類。它們專門中和真菌劑和皮癬菌，例如念珠菌和絛蟲，並有助於治療腳氣、癬、曲霉病、念珠菌病和真菌性腦膜炎。這些藥物通常以非處方 (OTC) 膠囊、凝膠、液體和藥丸形式提供，或直接注入血液中的靜脈注射溶液，以最大程度地減少和預防真菌感染。

抗真菌藥物市場趨勢：

真菌和醫院感染的日益流行是創造市場成長積極前景的關鍵因素之一。抗真菌藥物可有效對抗因暴露於醫院或潮濕環境中受污染的表面而引起的全身感染和表淺感染。此外，城鄉地區非處方藥的便捷取得也為市場成長提供了動力。隨著大眾健康意識的不斷增強，消費者擴大選擇非處方藥來及時治療輕微感染。此外，各種產品創新，例如用於治療侵襲性真菌感染的合成和半合成唑類化合物的開發，也是其他生長誘導因素。藥廠也廣泛投資於噴霧劑、乳膏、片劑和注射等新型療法的研發（R&D），以增強療效。其他因素，包括製藥業的顯著成長，以及促進公共衛生的有利政府政策的實施，預計將推動市場成長。

本報告回答的關鍵問題

  • 2022年全球抗真菌藥物市場規模有多大？
  • 2023-2028年全球抗真菌藥物市場的預期成長率是多少？
  • COVID-19 對全球抗真菌藥物市場有何影響？
  • 推動全球抗真菌藥物市場的關鍵因素是什麼？
  • 根據藥物類別，全球抗真菌藥物市場的詳細情形如何？
  • 根據適應症，全球抗黴菌藥物市場的細分如何？
  • 全球抗真菌藥物市場的重點區域有哪些？
  • 全球抗真菌藥物市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球抗真菌藥物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按藥物類別分類的市場細分

  • 唑類
    • 市場走向
    • 關鍵環節
      • 伏立康唑（Vfend）
      • 泊沙康唑（諾沙非）
      • 克黴唑（Canesten）
      • 艾沙康唑 (CRESEMBA)
      • 其他
    • 市場預測
  • 棘白菌素
    • 市場走向
    • 關鍵環節
      • 卡泊芬淨（Cancidas）
      • 米卡芬淨（Mycamine/ Funguard）
      • 其他
    • 市場預測
  • 多烯
    • 市場走向
    • 關鍵環節
      • 兩性黴素（AmBisome）
      • 其他
    • 市場預測
  • 烯丙胺
    • 市場走向
    • 關鍵環節
      • 特比萘芬（蘭美抒）
      • 其他
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按跡象分類的市場

  • 皮癬菌病
    • 市場走向
    • 市場預測
  • 麴菌病
    • 市場走向
    • 市場預測
  • 念珠菌病
    • 市場走向
    • 關鍵環節
      • 侵襲性念珠菌病
      • 外陰陰道念珠菌病 (VVC)
      • 口腔/喉嚨/食道念珠菌病
      • 其他
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Arcadia Consumer Healthcare Inc.
    • Astellas Pharma Inc.
    • Bayer AG
    • GlaxoSmithKline Plc
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Scynexis Inc.
Product Code: SR112023A3933

Abstract

The global antifungal drugs market size reached US$ 14.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.0 Billion by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2022-2028.

Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete's foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.

Antifungal Drugs Market Trends:

The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections. Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class and indication.

Breakup by Drug Class:

Azoles

Voriconazole (Vfend)

Posaconazole (Noxafil)

Clotrimazole (Canesten)

Isavuconazole (CRESEMBA)

Others

Echinocandins

Caspofungin (Cancidas)

Micafungin (Mycamine/ Funguard)

Others

Polyenes

Amphotericin (AmBisome)

Others

Allylamines

Terbinafine (Lamisil)

Others

Others

Breakup by Indication:

Dermatophytosis

Aspergillosis

Candidiasis

Invasive Candidiasis

Vulvovaginal Candidiasis (VVC)

Mouth/Throat/Esophageal Candidiasis

Others

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global antifungal drugs market in 2022?
  • 2. What is the expected growth rate of the global antifungal drugs market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global antifungal drugs market?
  • 4. What are the key factors driving the global antifungal drugs market?
  • 5. What is the breakup of the global antifungal drugs market based on the drug class?
  • 6. What is the breakup of the global antifungal drugs market based on the indication?
  • 7. What are the key regions in the global antifungal drugs market?
  • 8. Who are the key players/companies in the global antifungal drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antifungal Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Azoles
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Voriconazole (Vfend)
      • 6.1.2.2 Posaconazole (Noxafil)
      • 6.1.2.3 Clotrimazole (Canesten)
      • 6.1.2.4 Isavuconazole (CRESEMBA)
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Echinocandins
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Caspofungin (Cancidas)
      • 6.2.2.2 Micafungin (Mycamine/ Funguard)
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Polyenes
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Amphotericin (AmBisome)
      • 6.3.2.2 Others
    • 6.3.3 Market Forecast
  • 6.4 Allylamines
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Terbinafine (Lamisil)
      • 6.4.2.2 Others
    • 6.4.3 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Dermatophytosis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Aspergillosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Candidiasis
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Invasive Candidiasis
      • 7.3.2.2 Vulvovaginal Candidiasis (VVC)
      • 7.3.2.3 Mouth/Throat/Esophageal Candidiasis
      • 7.3.2.4 Others
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Arcadia Consumer Healthcare Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Astellas Pharma Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bayer AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 GlaxoSmithKline Plc
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Merck & Co. Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Pfizer Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sanofi S.A.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Scynexis Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials

List of Figures

  • Figure 1: Global: Antifungal Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Antifungal Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Antifungal Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Antifungal Drugs Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Antifungal Drugs Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Antifungal Drugs Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Antifungal Drugs (Azoles) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Antifungal Drugs (Azoles) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Antifungal Drugs (Echinocandins) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Antifungal Drugs (Echinocandins) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Antifungal Drugs (Polyenes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Antifungal Drugs (Polyenes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Antifungal Drugs (Allylamines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Antifungal Drugs (Allylamines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Antifungal Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Antifungal Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Antifungal Drugs (Dermatophytosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Antifungal Drugs (Dermatophytosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Antifungal Drugs (Aspergillosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Antifungal Drugs (Aspergillosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Antifungal Drugs (Candidiasis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Antifungal Drugs (Candidiasis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Antifungal Drugs (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Antifungal Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: North America: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: North America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: United States: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: United States: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Canada: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Canada: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Asia-Pacific: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Asia-Pacific: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: China: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: China: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Japan: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Japan: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: India: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: India: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: South Korea: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: South Korea: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Australia: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Australia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Indonesia: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Indonesia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Europe: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Europe: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Germany: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Germany: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: France: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: France: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: United Kingdom: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: United Kingdom: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Italy: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Italy: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Spain: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Spain: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Russia: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Russia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Latin America: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Latin America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Brazil: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Brazil: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Mexico: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Mexico: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Middle East and Africa: Antifungal Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Middle East and Africa: Antifungal Drugs Market: Breakup by Country (in %), 2022
  • Figure 73: Middle East and Africa: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Global: Antifungal Drugs Industry: SWOT Analysis
  • Figure 75: Global: Antifungal Drugs Industry: Value Chain Analysis
  • Figure 76: Global: Antifungal Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antifungal Drugs Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Antifungal Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Antifungal Drugs Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Antifungal Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Antifungal Drugs Market: Competitive Structure
  • Table 6: Global: Antifungal Drugs Market: Key Players